These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32268770)

  • 21. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K; Masajtis-Zagajewska A; Nowicki M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
    El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC
    Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes.
    Kim WJ; Kim SS; Lee HC; Song SH; Bae MJ; Yi YS; Jeon YK; Kim BH; Kim YK; Kim IJ
    J Korean Med Sci; 2015 May; 30(5):586-90. PubMed ID: 25931789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor-23 and cardiac structure and function.
    Agarwal I; Ide N; Ix JH; Kestenbaum B; Lanske B; Schiller NB; Whooley MA; Mukamal KJ
    J Am Heart Assoc; 2014 Feb; 3(1):e000584. PubMed ID: 24525546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease.
    Masai H; Joki N; Sugi K; Moroi M
    Atherosclerosis; 2013 Jan; 226(1):228-33. PubMed ID: 23137826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of fibroblast growth factor 23 and fetuin-A with coronary plaque burden and plaque composition in young adults.
    Akin F; Celik O; Ayca B; Altun I; Diker VO; Bıyık I; Siriopol D; Covic A; Kanbay M
    J Investig Med; 2015 Apr; 63(4):613-9. PubMed ID: 25679296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients.
    Kurnatowska I; Grzelak P; Kaczmarska M; Stefańczyk L; Nowicki M
    Nephron Clin Pract; 2011; 117(4):c297-304. PubMed ID: 20861651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of coronary artery calcium to cardiovascular risk in patients with combined diabetes mellitus and systemic hypertension.
    Shemesh J; Motro M; Morag-Koren N; Konen E; Grossman E
    Am J Cardiol; 2012 Mar; 109(6):844-50. PubMed ID: 22196788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.
    Aceña A; Franco-Peláez JA; Gutierrez-Landaluce C; Pello AM; Cristóbal C; Tarín N; Huelmos A; Carda R; Martín-Mariscal ML; Alonso J; González-Parra E; González-Casaus ML; Lorenzo Ó; López Bescos L; Egido J; Tuñón J
    Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):762-767. PubMed ID: 28803689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients.
    Yang J; Dou G; Tesche C; De Cecco CN; Jacobs BE; Schoepf UJ; Chen Y
    BMC Cardiovasc Disord; 2019 Feb; 19(1):39. PubMed ID: 30744612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients.
    Bozic M; Betriu A; Bermudez-Lopez M; Ortiz A; Fernandez E; Valdivielso JM;
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):577-584. PubMed ID: 29519952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients.
    Inaba M; Okuno S; Imanishi Y; Yamada S; Shioi A; Yamakawa T; Ishimura E; Nishizawa Y
    Osteoporos Int; 2006 Oct; 17(10):1506-13. PubMed ID: 16896512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
    Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive Predictors of Malignant Arrhythmias.
    Golukhova EZ; Gromova O; Grigoryan M; Merzlyakov V; Shumkov K; Bockeria L; Serebruany VL
    Cardiology; 2016; 135(1):36-42. PubMed ID: 27188395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study.
    Cho JH; Lee DY; Lee ES; Kim J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    Int J Cardiol; 2016 Nov; 222():233-237. PubMed ID: 27497100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fibroblast growth factor-21 as a marker of premature aging in young and middled-aged men with type 2 diabetes].
    Zagarskikh EY; Proshchai GA; Vorokhobina NV
    Urologiia; 2018 Mar; (1):92-95. PubMed ID: 29634140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up.
    Lenart-Lipińska M; Matyjaszek-Matuszek B; Gernand W; Nowakowski A; Solski J
    Diabetes Res Clin Pract; 2013 Aug; 101(2):194-200. PubMed ID: 23768789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.